Yoheng Shu

Title: Yoheng Shu: Innovator in Calcium Channel Antagonists

Introduction

Yoheng Shu is a notable inventor based in Blue Bell, PA (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target T-type calcium channels. His work is essential for advancing treatments for various disorders and diseases.

Latest Patents

Yoheng Shu holds a patent for "Heterocycle amide T-type calcium channel antagonists." This invention focuses on heterocycle amide compounds that act as antagonists of T-type calcium channels. These compounds are valuable in the treatment or prevention of disorders where T-type calcium channels play a crucial role. The patent also encompasses pharmaceutical compositions that include these compounds, highlighting their potential in medical applications.

Career Highlights

Yoheng Shu is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to contribute to innovative solutions in the pharmaceutical industry. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.

Collaborations

Yoheng Shu has collaborated with esteemed colleagues such as James C Barrow and Kelly-Ann S Schlegel. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic options.

Conclusion

Yoheng Shu's contributions to the field of calcium channel antagonists exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.